MARKET

ASXC

ASXC

Asensus Surgical Inc
AMEX
0.2850
+0.0050
+1.79%
After Hours: 0.2924 +0.0074 +2.60% 16:11 03/18 EDT
OPEN
0.2899
PREV CLOSE
0.2800
HIGH
0.2920
LOW
0.2800
VOLUME
649.19K
TURNOVER
0
52 WEEK HIGH
0.8600
52 WEEK LOW
0.2040
MARKET CAP
75.50M
P/E (TTM)
-0.8732
1D
5D
1M
3M
1Y
5Y
Options Volatility and Implied Earnings Moves This Week, March 18 – March 21, 2024
TipRanks · 15h ago
Weekly Report: what happened at ASXC last week (0311-0315)?
Weekly Report · 15h ago
Asensus Surgical, Inc. Schedules Fourth Quarter and Full Year 2023 Financial and Operating Results Conference Call for March 21, 2024
Asensus Surgical, Inc. Plans to release fourth quarter and full year 2023 financial and operating results after the market closes on March 21, 2024. The company is digitizing the interface between the surgeon and the patient. The Company will host a conference call to discuss these results.
Barchart · 3d ago
Weekly Report: what happened at ASXC last week (0304-0308)?
Weekly Report · 03/11 11:49
Weekly Report: what happened at ASXC last week (0226-0301)?
Weekly Report · 03/04 11:52
Asensus Surgical to Participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference
Asensus Surgical, Inc. Will participate in the Oppenheimer 34th Annual Healthcare MedTech & Services Conference. The Company's virtual presentation will take place on March 12, 2024 at 4:40 pm Eastern Time. Shameze Rampertab, Executive Vice President and Chief Financial Officer.
Barchart · 02/28 05:55
Asensus Surgical Celebrates 1,000 Senhance Cases Completed at Three Global Hospitals
Asensus Surgical, Inc. Announced the completion of more than 1,000 successful cases each at three hospitals utilizing the Senhance® Surgical System. The company is digitizing the interface between the surgeon and the patient. Three hospitals in Russia, Kazakhstan and Germany are using the system.
Barchart · 02/27 05:55
Weekly Report: what happened at ASXC last week (0219-0223)?
Weekly Report · 02/26 12:09
More
About ASXC
Asensus Surgical, Inc. is a medical device company. The Company is engaged in digitizing the interface between the surgeon and patient to reimagine surgery through Performance-Guided Surgery (PGS), by unlocking clinical intelligence to enable surgeons to deliver consistently superior outcomes to patients and establish a new standard of surgery. The Company is focused on the market development for and commercialization of the Senhance Surgical System, which digitizes laparoscopic minimally invasive surgery (MIS). The Senhance System is a digital, multi-port laparoscopic platform designed to maintain laparoscopic MIS standards while providing digital benefits such as haptic feedback, robotic precision, comfortable ergonomics, advanced instrumentation including 3 millimeters (mm) micro-laparoscopic instruments, 5mm articulating instruments, eye-sensing camera control and fully-reusable standard instruments to help maintain per-procedure costs similar to traditional laparoscopy.

Webull offers Asensus Surgical Inc stock information, including AMEX: ASXC real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, ASXC stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading ASXC stock methods without spending real money on the virtual paper trading platform.